Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 version 1.0 viral load test.

Academic Article


  • Acquired Immunodeficiency Syndrome, Anti-HIV Agents, Anti-Retroviral Agents, Cost of Illness, HIV-1, Humans, RNA, Viral, Viral Load, Viremia
  • Digital Object Identifier (doi)

    Author List

  • Willig JH; Nevin CR; Raper JL; Saag MS; Mugavero MJ; Willig AL; Burkhardt JH; Schumacher JE; Johnson VA
  • Start Page

  • 442
  • End Page

  • 444
  • Volume

  • 54
  • Issue

  • 4